Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-43890
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
IBM Security Verify Privilege On-Premises information disclosure
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM Security Verify Privilege On-Premises 11.5 could disclose sensitive information through an HTTP request that could aid an attacker in further attacks against the system. IBM X-Force ID: 240453.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
信息暴露
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Security Verify Privilege On-Premises 信息泄露漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM Security Verify Privilege是美国国际商业机器(IBM)公司的一个解决方案,用于管理和保护用户的身份和权限。 IBM Security Verify Privilege On-Premises 11.5及之前版本存在信息泄露漏洞,该漏洞源于可以通过HTTP请求泄露敏感信息。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMSecurity Verify Privilege On-Premises 11.5 -
II. Public POCs for CVE-2022-43890
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-43890
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-43890

No comments yet


Leave a comment